Latest Form 4 insider transactions

NASDAQ
John A Deford, a Director of Nordson Corp, received 84 shares of common stock on July 31, 2026.
NASDAQ
Robert H Kluge, a Director of Richardson Electronics, Ltd., sold 29,000 shares of common stock on July 30, 2026 for $17.90 per share.
NASDAQ
Shawn M Mclevige, EVP and President, Aerospace of Woodward, Inc., sold 2,150 shares of common stock on July 31, 2026 for $356.82 per share.
NASDAQ
Joseph M Rutledge, VP, CAO of Nordson Corp, reported a transaction in 274 shares of common stock on July 31, 2026.
NYSE
Barney Tianhao Wang, a Director of SharkNinja, Inc., received 861 shares of common stock on July 30, 2026.
NASDAQ
Sefton Cohen, Chief Revenue Officer of Research Solutions, Inc., reported a transaction in 284,000 shares of common stock on July 31, 2026.
NASDAQ
Bluerock Acquisition Corp. announced a definitive Business Combination Agreement with Yellow.ai, a global leader in enterprise agentic AI, expected to take Yellow.ai public on Nasdaq.
NASDAQ
Rajesh Raj Natarajan, Chief Technology Officer of Gorilla Technology Group Inc., reported a transaction in 78,658 shares of common stock on July 13, 2026.
NASDAQ
Amit Kumar, Chief Executive Officer and a Director of Anixa Biosciences Inc, purchased 5,000 shares of common stock on July 31, 2026 for $3.47 per share.
NASDAQ
Space-Eyes, Inc. showcased its advanced counter-drone technology, Morpheus, in media appearances, coinciding with its proposed business combination with McKinley Acquisition Corporation.
NASDAQ
Supernus Pharmaceuticals and Indivior Pharmaceuticals announced a merger of equals to create a diversified CNS biopharmaceutical leader with significant scale and an expanded portfolio of 11 medicines.
NASDAQ
Indivior Pharmaceuticals and Supernus Pharmaceuticals announced a merger of equals to create a diversified CNS biopharmaceutical company with significant scale and projected annual cost synergies of at least $125 million.
NYSE
Ava L Parker, a Director of Orchid Island Capital, Inc., received 1,791 shares of common stock on July 31, 2026.
NASDAQ
Stephen Distler, a Director of Princeton Bancorp, Inc., sold 8,776 shares of common stock on July 31, 2026 for $41.48 per share.
NASDAQ
Guy Avidan, Chief Financial Officer of Radware Ltd, purchased 2,000 shares of common stock on July 31, 2026 for $25.21 per share.
NASDAQ
Michael H Carrel, President, CEO, & Director and a Director of AtriCure, Inc., reported multiple transactions in common stock on July 30, 2026.
NASDAQ
Nikolaos Reskos, Chief Operating Officer of Star Bulk Carriers Corp., sold 5,000 shares of common stock on July 30, 2026 for $28.99 per share.
NASDAQ
David Moreno, President of FTAI Aviation Ltd., purchased 2,475 shares of common stock on July 31, 2026 for $201.27 per share.
NYSE
Bracken Darrell, President & Chief Exec Officer and a Director of V F Corp, purchased 32,894 shares of common stock on July 31, 2026 for $14.98 per share.
NASDAQ
Indivior Pharmaceuticals announced robust second quarter 2026 financial results, exceeding expectations and leading to an upward revision of full-year guidance, alongside progress on its merger with Supernus.
NASDAQ
Supernus Pharmaceuticals and Indivior Pharmaceuticals announced a merger of equals, creating a diversified CNS biopharmaceutical company with expected annual cost synergies of $125 million.
NASDAQ
Indivior Pharmaceuticals and Supernus Pharmaceuticals announce a merger of equals, creating a diversified CNS biopharmaceutical company named Supernus, Inc.
NASDAQ
Kwok Hin Tang, a Director of Aurora Mobile Ltd, reported multiple transactions in common stock on August 1, 2026.
NYSE
Mitsubishi Ufj Financial Group Inc reported changes in beneficial ownership of Mitsubishi Ufj Financial Group Inc common stock on July 30, 2026.
NYSE
Mitsubishi Ufj Financial Group Inc reported changes in beneficial ownership of Morgan Stanley common stock on July 30, 2026.
NASDAQ
Skyworks Solutions provides an update on its merger with Qorvo, noting progress on antitrust reviews and aiming for year-end closing.
NASDAQ
Skyworks Solutions provides an update on its merger with Qorvo, noting progress on antitrust reviews and aiming for year-end closing.
NYSE
Longgen Zhang, a Director of X Financial, reported a transaction in 90,000 shares of common stock on August 1, 2026.
NASDAQ
Hon Sang Lee, a Director of Aurora Mobile Ltd, reported multiple transactions in common stock on August 1, 2026.
NASDAQ
Skyworks Solutions, Inc. filed an 8-K detailing the ongoing merger with Qorvo, Inc., including financial statements of Qorvo and pro forma combined financial information, while noting regulatory reviews and exchange offers.